|1.||Jones, Ronald N: 16 articles (02/2012 - 02/2002)|
|2.||Naber, K G: 11 articles (02/2011 - 04/2001)|
|3.||Wagenlehner, F M E: 9 articles (03/2014 - 03/2004)|
|4.||Jones, R N: 9 articles (12/2001 - 06/2000)|
|5.||Jarlier, Vincent: 7 articles (03/2015 - 01/2006)|
|6.||Veziris, Nicolas: 7 articles (03/2015 - 01/2006)|
|7.||Hsueh, Po-Ren: 7 articles (04/2014 - 09/2007)|
|8.||Blasi, Francesco: 7 articles (01/2014 - 01/2004)|
|9.||Stahlmann, Ralf: 7 articles (12/2012 - 02/2002)|
|10.||Naber, Kurt G: 7 articles (02/2012 - 10/2003)|
01/01/2007 - "Fluoroquinolones are broad-spectrum antimicrobials highly effective in the treatment of a wide variety of clinical infections. "
05/01/2005 - "Fluoroquinolones are broad-spectrum antimicrobials highly effective for treatment of a variety of clinical and veterinary infections. "
01/01/1999 - "When the causative pathogens are susceptible, the fluoroquinolones have been demonstrated to be highly efficacious in the treatment of both mild uncomplicated skin and skin structure infections as well as the more severe complicated infections involving these tissues, including infections of the feet of diabetic patients. "
08/01/2004 - "The Chilean situation triggers important concerns because it includes the use of fluoroquinolones in aquaculture, that are not biodegradable and are able to remain in the environment for years as well as being still effective in treating human infections. "
04/01/1994 - "Fluoroquinolones have been used frequently as first-line therapy and have provided excellent clinical efficacy for gonococcal infections for the last several years in Japan. "
|2.||Urinary Tract Infections (Urinary Tract Infection)
04/01/2012 - "The advent of this resistance mechanism involves a more rational use of fluoroquinolones, especially as first-line treatment of urinary tract infections."
04/01/2015 - "The purpose of this study was to evaluate which of blood or urine has the greater effect on bladder tissue concentrations of fluoroquinolones important for the treatment of urinary tract infections by measuring concentrations of fluoroquinolones in the vesical tissue (chemically and immunohistochemically) and intravesical space (chemically). "
04/01/2012 - "This study was led in Franche-Comté, a French eastern region, where GPs were given a guideline recommending a restricted use of fluoroquinolones for urinary tract infections. "
01/01/2012 - "Evaluating the impact of corrective measures on fluoroquinolones (FQ) prescriptions for urinary tract infections (UTI) during a 2-round relevance study on a regional scale. "
01/01/2012 - "[Impact of corrective measures on fluoroquinolones prescriptions for urinary tract infections during a 2-round relevance study]."
|3.||Respiratory Tract Infections (Respiratory Tract Infection)
04/01/2003 - "The results from this pharmacodynamic study suggest that these fluoroquinolones would have prolonged killing activity against these organisms in vivo and may have clinical utility in the treatment of mixed aerobic-anaerobic respiratory tract infections."
01/01/2002 - "Clinical trials comparing the new fluoroquinolones to each other or to standard therapy have demonstrated good efficacy in a variety of community-acquired respiratory infections (e.g. "
10/01/2000 - "Because of increasing resistance to older drugs, the newer fluoroquinolones have a role in the therapy of CAP and other respiratory infections, although surveillance studies must continue."
01/01/2015 - "Although fluoroquinolones are commonly used to treat respiratory infections, the proportion of resistant NTHi isolates remains low. "
01/01/2015 - "Nontypeable Haemophilus influenzae (NTHi) is a common cause of respiratory infections in adults, who are frequently treated with fluoroquinolones. "
03/01/1993 - "The fluoroquinolones are effective in treating pneumonia because of their broad spectra of activity against gram-negative and gram-positive organisms, including Streptococcus pneumoniae and Haemophilus influenzae. "
05/22/2000 - "New fluoroquinolones with improved activity against S pneumoniae can also be used to treat adults with community-acquired pneumonia. "
07/01/2008 - "pneumoniae with additional mechanisms of resistance causes decreased efficacy of fluoroquinolones in a pneumonia model in mice."
10/01/2006 - "Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). "
12/02/2008 - "Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials."
|5.||Typhoid Fever (Typhoid)
05/01/2012 - "Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever."
01/01/2013 - "Fluoroquinolones are the most commonly used group of antimicrobials for the treatment of enteric fever, but no direct comparison between two fluoroquinolones has been performed in a large randomised trial. "
01/01/2008 - "Randomized controlled trials of fluoroquinolones in people with blood or bone marrow culture-confirmed enteric fever. "
01/01/2005 - "Randomized controlled trials of fluoroquinolones in people with blood or bone marrow culture-confirmed enteric fever. "
01/01/1996 - "The aim of the study was to document the effects of short courses of fluoroquinolones given during an outbreak of multidrug resistant typhoid fever in southern Viet Nam on the growth of children over a period of two years. "
|3.||Cephalosporins (Cephalosporin Antibiotics)
|4.||Anti-Bacterial Agents (Antibiotics)
|9.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|1.||Drug Therapy (Chemotherapy)
|2.||Home Nursing (Nursing, Home)
|3.||Continuous Ambulatory Peritoneal Dialysis (CAPD)
|4.||Intensive Care (Surgical Intensive Care)